ELI LILLY & Co (LLY) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ELI LILLY & Co.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
LLY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- LLY has a higher average analyst price target than 93.56% of all US stocks.
- ELI LILLY & Co's number of analysts covering the stock is greater than 95.45% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of LLY is greater than 11.67% of Pharmaceutical Products stocks.
- LLY has a lower variance in analysts' estimates than 60.91% of Pharmaceutical Products stocks.
- LLY has a lower percent of analysts bearish on the stock than almost 100% of all US stocks.
- LLY has a greater percentage of analysts bullish on the stock than practically none of all US stocks.
- The change in bullishness amongst analysts of LLY is less than almost 100% of all US stocks.
What is the outlook for LLY? Use POWR Ratings for clearer insight into price direction.